SCHEMBL2463695

SCHEMBL2463695

CCCCCCCOc1ccc(CCC(CO)(CO[PH](=O)C(Cc2ccccc2)c2ccccc2)NC(=O)OCc2ccccc2)cc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 4/20 0.46
THRA P10827 1/20 0.34
THRB P10828 1/20 0.34
CNR2 P34972 1/20 0.33
PPARG P37231 4/20 0.33
PPARD Q03181 1/20 0.33
PPARA Q07869 1/20 0.33
POLB P06746 1/20 0.33
MBOAT4 Q96T53 1/20 0.32
LTB4R Q15722 1/20 0.32
ITGB3 P05106 4/20 0.32
ITGA2B P08514 4/20 0.32
S1PR4 O95977 1/20 0.32
S1PR3 Q99500 1/20 0.32
S1PR5 Q9H228 1/20 0.32
TLR2 O60603 1/20 0.32
ALOX5 P09917 1/20 0.32
PSEN1 P49768 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL78876 0.90 ITGB3 (0.39) S1PR1PPARGITGB3ITGA2BALOX5
SCHEMBL79822 0.88 S1PR1 (0.35) S1PR1S1PR4S1PR3S1PR5
SCHEMBL2466970 0.86 S1PR1 (0.59) S1PR1THRATHRBPPARGPPARD
SCHEMBL80550 0.86 PPARG (0.36) S1PR1PPARGPPARDPPARAITGB3
SCHEMBL81201 0.85 S1PR1 (0.33) S1PR1PPARGPPARDPPARAITGB3
SCHEMBL13851930 0.82 S1PR1 (0.53) S1PR1THRATHRBCNR2PPARG
SCHEMBL2463693 0.82 S1PR1 (0.50) S1PR1THRATHRBPPARGPPARD
SCHEMBL2463726 0.81 ALDH1A1 (0.39) S1PR1PPARGS1PR3
SCHEMBL2466790 0.81 ALDH1A1 (0.39) S1PR1PPARGS1PR3
SCHEMBL80081 0.80 AAK1 (0.35) S1PR1PPARGPPARDPPARAITGB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140296183-A1 AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES MITSUBISHI TANABE PHARMA CORP (JP) 2014-10-02 US disclosed
US-8809304-B2 Amine compound and use thereof for medical purposes MITSUBISHI TANABE PHARMA CORPORATION (JP) 2014-08-19 US disclosed
EP-1961734-B1 AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES MITSUBISHI TANABE PHARMA CORP (JP) 2011-09-14 EP disclosed
US-20090137530-A1 Amine Compound and Use Thereof for Medical Purposes MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090137530-A1 Amine Compound and Use Thereof for Medical Purposes HRH3, HRH2, HRH4 S1PR1 370/4885THRA 705/4885THRB 536/4885
US-20140296183-A1 AMINE COMPOUND AND USE THEREOF FOR MEDICAL PURPOSES HRH3, HRH2, HRH4 S1PR1 370/4885THRA 705/4885THRB 536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.